Ono Pharmaceutical EBITDA Margin 2010-2024 | OPHLF

Ono Pharmaceutical ebitda margin for the quarter ending December 31, 2024 was 36.85%.

  • Ono Pharmaceutical average ebitda margin for 2023 was 39.47%, a 3.79% decline from 2022.
  • Ono Pharmaceutical average ebitda margin for 2022 was 38.03%, a 7.46% increase from 2021.
  • Ono Pharmaceutical average ebitda margin for 2021 was 35.39%, a 8.89% increase from 2020.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

Ono Pharmaceutical EBITDA Margin 2010-2024 | OPHLF

  • Ono Pharmaceutical average ebitda margin for 2023 was 39.47%, a 3.79% decline from 2022.
  • Ono Pharmaceutical average ebitda margin for 2022 was 38.03%, a 7.46% increase from 2021.
  • Ono Pharmaceutical average ebitda margin for 2021 was 35.39%, a 8.89% increase from 2020.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.